Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Benzedrex
2. Propylhexadrine
3. Propylhexedrine Hydrochloride
4. Propylhexedrine Hydrochloride, (s)-isomer
1. Benzedrex
2. Hydromethamphetamine
3. Propylhexedrin
4. Dristan
5. Obesin
6. Hexahydrodesoxyephedrine
7. Dristan Inhaler
8. Chp-depot
9. 1-cyclohexyl-n-methylpropan-2-amine
10. 101-40-6
11. Propylhexadrine
12. Propylhexedrinum
13. Dl-propylhexedrine
14. Methyl-(1-methyl-2-cyclohexylethyl)amine
15. 1-cyclohexyl-2-(methylamino)propane
16. 1-cyclohexyl-n-methyl-2-propanamine
17. (+/-) Propylhexedrine
18. N,alpha-dimethylcyclohexaneethylamine
19. Nsc 32410
20. 1-cyclohexyl-2-methylaminopropan
21. Cyclohexaneethanamine, N,.alpha.-dimethyl-
22. Nsc-32410
23. Lqu92iu8ll
24. Ncgc00182042-01
25. Cyclohexaneethylamine, N-.alpha.-dimethyl-
26. Propilhexedrina
27. Propilesedrina
28. Propilesedrina [dcit]
29. Einecs 202-939-3
30. Unii-lqu92iu8ll
31. Brn 3194303
32. Propylhexedrinum [inn-latin]
33. 1-cyclohexyl-2-methylaminopropan [german]
34. Propilhexedrina [inn-spanish]
35. (+-)-n,alpha-dimethylcyclohexaneethylamine
36. (cyclohexaneethyl)amine, N-alpha-dimethyl-
37. Beta-cyclohexyl-isopropylmethylamin [german]
38. Propylhexedrine [usp:inn:ban]
39. Beta-cyclohexyl-isopropylmethylamin
40. Cyclohexaneethanamine, N,alpha-dimethyl-, (+-)
41. Einecs 222-741-0
42. Dristan Inhaler (tn)
43. Propylhexedrine Dl-form
44. Dsstox_cid_3526
45. Cyclohexaneethylamine, Alpha,n-dimethyl-
46. Propylhexedrine (usp/inn)
47. Dsstox_rid_77064
48. Cyclohexaneethanamine, N,alpha-dimethyl-, (+-)-
49. Dsstox_gsid_23526
50. Schembl28537
51. Propylhexedrine [inn]
52. 3-12-00-00108 (beilstein Handbook Reference)
53. Propylhexedrine [vandf]
54. Propylhexedrine [mart.]
55. Chembl2105275
56. Dtxsid1023526
57. Propylhexedrine [who-dd]
58. Schembl20780004
59. Wln: L6tj A1y1&m1
60. Chebi:134783
61. N-methyl-1-cyclohexylisopropylamine
62. Nsc32410
63. Tox21_113077
64. Propylhexedrine Dl-form [mi]
65. Stk664138
66. Akos005172629
67. .alpha.,n-dimethylcyclohexaneethylamine
68. Cyclohexaneethanamine,.alpha.-dimethyl-
69. Db06714
70. N,.alpha.-dimethylcyclohexaneethylamine
71. Propylhexedrine [usp Monograph]
72. (1-cyclohexylpropan-2-yl)(methyl)amine
73. Ncgc00182042-03
74. Ncgc00182042-04
75. 3595-11-7
76. Cas-101-40-6
77. N-.alpha.-(dimethylcyclohexane)ethylamine
78. Cyclohexaneethylamine, .alpha.,n-dimethyl-
79. Ft-0674106
80. (cyclohexaneethyl)amine, N-.alpha.-dimethyl-
81. N-(2-cyclohexyl-1-methylethyl)-n-methylamine
82. D05637
83. Ab01331925-02
84. (.+/-.)-n,.alpha.-dimethylcyclohexaneethylamine
85. Q408704
86. (+/-)-n,.alpha.-dimethylcyclohexaneethanamine
87. Cyclohexaneethanamine, N,.alpha.-dimethyl-, (.+/-.)
| Molecular Weight | 155.28 g/mol |
|---|---|
| Molecular Formula | C10H21N |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 3 |
| Exact Mass | 155.167399674 g/mol |
| Monoisotopic Mass | 155.167399674 g/mol |
| Topological Polar Surface Area | 12 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 95 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
It is used to provide temporary symptomatic relief of nasal congestion due to colds, allergies and allergic rhinitis.
Like other monoamine releasing stimulants propylhexedrine is active as a norepinephrine and dopamine releaser in the central nervous system. The acute effects of the drug closely resemble the physiological and psychological effects of an epinephrine-provoked fight-or-flight response, including increased heart rate and blood pressure, vasoconstriction (constriction of the arterial walls), bronchodilation, and hyperglycemia (increased blood sugar).
Propylhexidrine causes the norepinephrine, dopamine, and serotonin (5HT) transporters to reverse their direction of flow. This inversion leads to a release of these transmitters from the vesicles to the cytoplasm and from the cytoplasm to the synapse. It also antagonizes the action of VMAT2, causing the release of more neurotransmitters.
ABOUT THIS PAGE
A Propylhexedrine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Propylhexedrine, including repackagers and relabelers. The FDA regulates Propylhexedrine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Propylhexedrine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Propylhexedrine supplier is an individual or a company that provides Propylhexedrine active pharmaceutical ingredient (API) or Propylhexedrine finished formulations upon request. The Propylhexedrine suppliers may include Propylhexedrine API manufacturers, exporters, distributors and traders.
click here to find a list of Propylhexedrine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Propylhexedrine DMF (Drug Master File) is a document detailing the whole manufacturing process of Propylhexedrine active pharmaceutical ingredient (API) in detail. Different forms of Propylhexedrine DMFs exist exist since differing nations have different regulations, such as Propylhexedrine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Propylhexedrine DMF submitted to regulatory agencies in the US is known as a USDMF. Propylhexedrine USDMF includes data on Propylhexedrine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Propylhexedrine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Propylhexedrine suppliers with USDMF on PharmaCompass.
Propylhexedrine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Propylhexedrine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Propylhexedrine GMP manufacturer or Propylhexedrine GMP API supplier for your needs.
A Propylhexedrine CoA (Certificate of Analysis) is a formal document that attests to Propylhexedrine's compliance with Propylhexedrine specifications and serves as a tool for batch-level quality control.
Propylhexedrine CoA mostly includes findings from lab analyses of a specific batch. For each Propylhexedrine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Propylhexedrine may be tested according to a variety of international standards, such as European Pharmacopoeia (Propylhexedrine EP), Propylhexedrine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Propylhexedrine USP).
LOOKING FOR A SUPPLIER?
